“…Proximity of cell-free hemoglobin to endothelial cells (Alayash, 2004), extravasation (Urbaitis et al, 1991), and depletion of vascular endothelium derived nitric oxide (NO) by extracellular-hemoglobin (Hb) (Alayash et al, 2007;Doherty et al, 1998;Olson et al, 2004) are the primary hypotheses for the vasoconstriction and increases in systemic and pulmonary blood pressures observed after HBOC infusion. Over the years, structural and chemical modifications have reduced extravasation of the HBOCs, mitigating some of their vasoconstrictive effects (Acharya et al, 2005). Sanguinate (Prolong Pharmaceuticals, South Plainfield, NJ, USA) is composed of a carbon monoxide (CO)-releasing purified bovine Hb conjugated with Microvascular Research 107 (2016) [83][84][85][86][87][88][89][90] Abbreviations: CCI, Controlled cortical impact; HBOC, hemoglobin based oxygen carrier; PbtO 2 , partial pressure of oxygen in brain interstitium; PO 2 , partial pressure of oxygen; PQM, phosphorescence quenching method; TBI, traumatic brain injury.…”